SurpassMD vs Fridays: Flat GLP-1 Pricing vs Coaching Compared
Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Read our ownership disclosure.
SurpassMD offers compounded semaglutide as low as $114/month and tirzepatide as low as $177/month, flat across every dose, with cold shipping within 48 hours of approval, an oral semaglutide option and nutrition guidance. Fridays also advertises both compounded medicines. Its strengths are 1:1 nutritionist coaching, ongoing support and insurance navigation for brand-name medication. The useful choice is the program and payment structure you will actually use.
Advertised Plans and Services: October 28, 2026
| Feature | SurpassMD | Fridays |
|---|---|---|
| Compounded semaglutide | As low as $114/mo; flat | Promotion from $99/mo; standard footer $150/mo paid annually / $249/mo month-to-month |
| Semaglutide annual standard offer | No prepayment lump sum required | Standard footer $150/mo paid annually; promotions differ |
| Compounded tirzepatide | As low as $177/mo; flat | Promotion from $198/mo; standard footer $240/mo paid annually / $359/mo month-to-month |
| Dose escalation | Flat — no increase with dose | Offer-specific base plan; do not infer price from dose alone |
| Brand-name path | Not offered | Ozempic and Zepbound advertised; insurance help |
| Oral semaglutide | Oral semaglutide; needle-free | Branded Wegovy pill advertised; compounded oral offer not established |
| Nutrition & coaching | Nutrition guidance included | 1:1 nutritionist and ongoing support |
| Insurance support | Cash-pay only | Yes, for brand medications |
| Shipping | Cold, within 48 hours of approval | Order-specific estimate; no delivery deadline verified |
| Billing | HSA/FSA, Klarna, cancel anytime | Promotional, monthly and annual standard offers; terms vary |
| Coverage | 50 states + DC | Subject to state and clinical eligibility |
Program vs Medication: What You Are Actually Buying
Checked October 28, 2026: Fridays’ pricing page advertises semaglutide from $99/month and tirzepatide from $198/month in promotional panels. The same page’s standard-plan footer lists semaglutide at $150/month paid annually or $249/month month-to-month, and tirzepatide at $240/month paid annually or $359/month month-to-month. These are distinct advertised offers, not one interchangeable checkout price. SurpassMD’s $114/$177 as-low-as rates reflect its longest subscription option without a prepayment lump sum and stay flat as dose changes. Related reading: GLP-1 tapering.
Fridays’ insurance-navigation service can be valuable when a plan covers an appropriate brand-name prescription. Coverage, deductibles, copays and any platform charge determine the actual patient cost; this review does not assign every insured patient a fixed copay. Read whether your plan covers GLP-1s for coverage questions. To explore the provider side of this decision, our GLP-1 Program Guide compares online weight-management programs.
Verdict: Which Should You Choose?
Choose SurpassMD for the flat $114/$177 as-low-as offers, no dose-based increase, cold shipping within 48 hours, oral semaglutide and included nutrition guidance. Choose Fridays when you will use its 1:1 coaching or brand-name insurance support. Fridays’ $99 semaglutide promotion is a lower headline than SurpassMD’s $114 offer, while SurpassMD keeps its stated rate flat across doses without a prepayment lump sum. The complete commitment and renewal terms decide the better fit.
Full reviews: SurpassMD review and Fridays review. See also best GLP-1 telehealth providers and the full price comparison.
Frequently Asked Questions
SurpassMD advertises semaglutide as low as $114/month, flat across doses, on its longest subscription option without a prepayment lump sum. Checked October 28, Fridays’ pricing page shows a $99/month promotion alongside a standard footer of $150/month paid annually or $249/month month-to-month. Those offers have different commitment and renewal conditions, so neither headline alone establishes the cheapest total plan.
Fridays advertises 1:1 nutritionist coaching, ongoing chat support, regular clinician consultations and insurance-navigation help for brand-name medications. SurpassMD includes nutrition guidance; Fridays’ more structured coaching and insurance service are its distinct strengths in this comparison.
Both advertise compounded tirzepatide. SurpassMD is as low as $177/month, flat across doses. Fridays’ current pricing page shows a promotion from $198/month and a standard footer of $240/month paid annually or $359/month month-to-month; it also advertises brand-name Zepbound. Match the specific offer and payment commitment before comparing totals.
Prepayment trades a lower advertised monthly figure for an upfront commitment and refund restrictions. Fridays’ standard footer lists $150/month paid annually, while current promotional panels show different prices. SurpassMD’s as-low-as $114 rate requires no prepayment lump sum and is cancel-anytime. Review the exact offer and your treatment plan before committing for a year.
SurpassMD advertises cold shipping within 48 hours of provider approval. Fridays provides online intake, clinician review, ongoing coaching and insurance-navigation support. A dispatch promise and a delivery estimate measure different stages; the reviewed Fridays pricing page does not establish a single delivery deadline for every order. Both advertise HSA/FSA payment options.
Choose SurpassMD for flat pricing as low as $114 semaglutide or $177 tirzepatide across all doses, 48-hour cold shipping, an oral semaglutide option and nutrition guidance. Choose Fridays for 1:1 accountability coaching or help pursuing insured brand-name medication. Compare its current promotional offer with its standard-plan commitment rather than assuming the $150 annual figure is always the best available price.
Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. A prescription is never guaranteed; eligibility is determined by an independent licensed provider.